Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)

ClinicalTrials.gov ID: NCT04210245

Public ClinicalTrials.gov record NCT04210245. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Efficacy, Safety and Tolerability of NGM282 (Aldafermin) in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (ALPINE 4)

Study identification

NCT ID
NCT04210245
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NGM Biopharmaceuticals, Inc
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

  • Placebo Other
  • aldafermin Biological

Other · Biological

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 22, 2020
Primary completion
Jan 3, 2023
Completion
Feb 22, 2023
Last update posted
Mar 25, 2025

2020 – 2023

United States locations

U.S. sites
31
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
NGM Clinical Study Site Glendale Arizona 85306
NGM Clinical Study Site 413 Tucson Arizona 85711
NGM Clinical Study Site 415 Tucson Arizona 85711
NGM Clinical Study Site North Little Rock Arkansas 72117
NGM Clinical Study Site Fresno California 93720
NGM Clinical Study Site La Jolla California 92037
NGM Clinical Study Site Los Angeles California 90057
NGM Clinical Study Site Panorama City California 91402
NGM Clinical Study Site Rialto California 92377
NGM Clinical Study Site Boca Raton Florida 33434
NGM Clinical Study Site Miami Florida 33136
NGM Clinical Study Site Marietta Georgia 30060
NGM Clinical Study Site Chicago Illinois 60611
NGM Clinical Study Site Chicago Illinois 60637
NGM Clinical Study Site Baltimore Maryland 21202
NGM Clinical Study Site Boston Massachusetts 02111
NGM Clinical Study Site Boston Massachusetts 02114
NGM Clinical Study Site Flowood Mississippi 39232
NGM Clinical Study Site 488 Jackson Mississippi 39216
NGM Clinical Study Site Kansas City Missouri 64131
NGM Clinical Study Site Durham North Carolina 27710
NGM Clinical Study Site Germantown Tennessee 38138
NGM Clinical Study Site Austin Texas 78746
NGM Clinical Study Site Edinburg Texas 78229
NGM Clinical Study Site Edinburg Texas 78539
NGM Clinical Study Site 481 Houston Texas 77030
NGM Clinical Study Site San Antonio Texas 78215
NGM Clinical Study Site San Antonio Texas 78229
NGM Clinical Study Site Richmond Virginia 23249
NGM Clinical Study Site Richmond Virginia 23298
NGM Clinical Study Site 482 Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04210245, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 25, 2025 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04210245 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →